Precigen (PGEN) to Release Quarterly Earnings on Wednesday

Precigen (NASDAQ:PGEN) is expected to be releasing its earnings data before the market opens on Wednesday, March 19th. Analysts expect Precigen to post earnings of ($0.06) per share and revenue of $1.30 million for the quarter.

Precigen Stock Performance

PGEN stock opened at $1.80 on Monday. Precigen has a 1 year low of $0.65 and a 1 year high of $2.17. The firm has a market cap of $527.16 million, a P/E ratio of -3.27 and a beta of 1.57. The stock’s 50 day moving average price is $1.55 and its 200 day moving average price is $1.13.

Analyst Ratings Changes

Several analysts recently issued reports on PGEN shares. JMP Securities reiterated a “market outperform” rating and issued a $5.00 price target on shares of Precigen in a report on Tuesday, January 14th. HC Wainwright restated a “buy” rating and issued a $6.00 price target (up previously from $4.00) on shares of Precigen in a research note on Thursday, January 23rd. Two analysts have rated the stock with a sell rating and four have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $7.00.

About Precigen

Precigen, Inc operates as a discovery and clinical-stage biopharmaceutical company that develops gene and cell therapies using precision technology to target diseases in therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases. It operates through two segments, Biopharmaceuticals and Exemplar.